Imatinib Resistance and Progression of CML to Blast Crisis: Somatic Hypermutation AIDing the Way

Cancer Cell

Volumn 16, Issue 3, 2009, Pages 174-176

  Strout, Matthew P ^a   Schatz, David G ^b  

^a YALE CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; IMATINIB;

BLAST CELL CRISIS; CANCER GROWTH; CANCER REGRESSION; CHRONIC MYELOID LEUKEMIA; DNA REPAIR; ENZYME ACTIVATION; GENOMIC INSTABILITY; POINT MUTATION; PRIORITY JOURNAL; SHORT SURVEY; SOMATIC HYPERMUTATION;

ANTINEOPLASTIC AGENTS; BLAST CRISIS; CELL LINE, TUMOR; CYTIDINE DEAMINASE; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MODELS, BIOLOGICAL; MUTATION; PIPERAZINES; PYRIMIDINES;

EID: 69249241826     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2009.08.012     Document Type: Short Survey

References (10)

1. Di Noia J.M., and Neuberger M.S. Annu. Rev. Biochem. 76 (2007) 1-22
2. Druker B.J. Blood 112 (2008) 4808-4817
3. Druker B.J., Guilhot F., O'Brien S.G., Gathmann I., Kantarjian H., Gattermann N., Deininger M.W., Silver R.T., Goldman J.M., Stone R.M., et al. N. Engl. J. Med. 355 (2006) 2408-2417
4. Garcia-Manero G., Faderl S., O'Brien S., Cortes J., Talpaz M., and Kantarjian H.M. Cancer 98 (2003) 437-457
5. Klemm L., Duy C., Iacobucci I., Kuchen S., von Levetzow G., Feldhahn N., Henke N., Li Z., Hoffmann T.K., Kim Y.-m., et al. Cancer Cell 16 (2009) 232-245 this issue
6. Okazaki I.M., Kotani A., and Honjo T. Adv. Immunol. 94 (2007) 245-273
7. Quintas-Cardama A., and Cortes J. Blood 113 (2009) 1619-1630
8. Takahashi N., Miura I., Saitoh K., and Miura A.B. Blood 92 (1998) 4758-4763
9. Tsai A.G., Lu H., Raghavan S.C., Muschen M., Hsieh C.L., and Lieber M.R. Cell 135 (2008) 1130-1142
10. Yu D., Allman D., Goldschmidt M.H., Atchison M.L., Monroe J.G., and Thomas-Tikhonenko A. Blood 101 (2003) 1950-1955